These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15530656)

  • 1. Allele-specific overexpression in astrocytes of an Alzheimer's disease associated alpha-1-antichymotrypsin promoter polymorphism.
    Ritchie A; Morgan K; Kalsheker N
    Brain Res Mol Brain Res; 2004 Nov; 131(1-2):88-92. PubMed ID: 15530656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in the alpha(1)-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations.
    Morgan K; Licastro F; Tilley L; Ritchie A; Morgan L; Pedrini S; Kalsheker N
    Hum Genet; 2001 Sep; 109(3):303-10. PubMed ID: 11702211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease.
    Wang X; DeKosky ST; Luedecking-Zimmer E; Ganguli M; Kamboh MI
    Hum Genet; 2002 Apr; 110(4):356-65. PubMed ID: 11941486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.
    Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N
    Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of alpha1-antichymotrypsin polymorphism with cerebral amyloid angiopathy.
    Yamada M; Sodeyama N; Itoh Y; Suematsu N; Otomo E; Matsushita M; Mizusawa H
    Ann Neurol; 1998 Jul; 44(1):129-31. PubMed ID: 9667601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.
    Licastro F; Pedrini S; Ferri C; Casadei V; Govoni M; Pession A; Sciacca FL; Veglia F; Annoni G; Bonafè M; Olivieri F; Franceschi C; Grimaldi LM
    Ann Neurol; 2000 Sep; 48(3):388-91. PubMed ID: 10976648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription factor Yin Yang 1 is an activator of BACE1 expression.
    Nowak K; Lange-Dohna C; Zeitschel U; Günther A; Lüscher B; Robitzki A; Perez-Polo R; Rossner S
    J Neurochem; 2006 Mar; 96(6):1696-707. PubMed ID: 16539685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of interleukin-1- and tumor necrosis factor alpha-dependent regulation of the alpha 1-antichymotrypsin gene in human astrocytes.
    Kordula T; Bugno M; Rydel RE; Travis J
    J Neurosci; 2000 Oct; 20(20):7510-6. PubMed ID: 11027208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The -980C/G polymorphism in APH-1A promoter confers risk of Alzheimer's disease.
    Qin W; Jia L; Zhou A; Zuo X; Cheng Z; Wang F; Shi F; Jia J
    Aging Cell; 2011 Aug; 10(4):711-9. PubMed ID: 21443683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A promoter polymorphism in the monoamine oxidase A gene is associated with the pineal MAOA activity in Alzheimer's disease patients.
    Wu YH; Fischer DF; Swaab DF
    Brain Res; 2007 Sep; 1167():13-9. PubMed ID: 17692293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides.
    Bourne KZ; Ferrari DC; Lange-Dohna C; Rossner S; Wood TG; Perez-Polo JR
    J Neurosci Res; 2007 May; 85(6):1194-204. PubMed ID: 17385716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease.
    Lahiri DK; Ge YW; Maloney B; Wavrant-De Vrièze F; Hardy J
    Neurobiol Aging; 2005; 26(10):1329-41. PubMed ID: 16243604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 1-antichymotrypsin/SerpinA3 is a novel target of orphan nuclear receptor Nur77.
    Zhao Y; Liu Y; Zheng D
    FEBS J; 2008 Mar; 275(5):1025-38. PubMed ID: 18248459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cytokines, dexamethasone and the A/T-signal peptide polymorphism on the expression of alpha(1)-antichymotrypsin in astrocytes: significance for Alzheimer's disease.
    Nilsson LN; Das S; Potter H
    Neurochem Int; 2001; 39(5-6):361-70. PubMed ID: 11578771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin.
    Kalsheker N; Morley S; Morgan K
    Biochem Soc Trans; 2002 Apr; 30(2):93-8. PubMed ID: 12023832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 induced polymerization of human alpha-1-antichymotrypsin and suppressed its protease inhibitory activity: implications for Alzheimer's disease.
    Licastro F; Davis LJ; Pedrini S; Galasko D; Masliah E
    Biochem Biophys Res Commun; 1998 Aug; 249(1):182-6. PubMed ID: 9705853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and uptake of A beta1-42 by primary human astrocytes in vitro.
    Nielsen HM; Veerhuis R; Holmqvist B; Janciauskiene S
    Glia; 2009 Jul; 57(9):978-88. PubMed ID: 19062178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration.
    Porcellini E; Calabrese E; Guerini F; Govoni M; Chiappelli M; Tumini E; Morgan K; Chappell S; Kalsheker N; Franceschi M; Licastro F
    Neurosci Lett; 2007 Apr; 416(1):66-70. PubMed ID: 17284348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation, antichymotrypsin, and lipid metabolism: autogenic etiology of Alzheimer's disease.
    Janciauskiene S; Wright HT
    Bioessays; 1998 Dec; 20(12):1039-46. PubMed ID: 10048303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.